Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Vivos Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −3 vs. Q1 2026
- Shares held
- 530.7K
- −1.29M (−70.9%) vs. Q1 2026
- Total value
- $242.7K
- −$1.90M (−88.7%) vs. Q1 2026
- New holders
- 2
- 3 more added
- Sold out
- 5
- 4 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VVOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $242.7K |
| Q1 2026 | 25 | $2.15M |
| Q4 2025 | 20 | $1.34M |
| Q3 2025 | 23 | $2.13M |
| Q2 2025 | 19 | $1.27M |
| Q1 2025 | 21 | $1.00M |
| Q4 2024 | 20 | $2.00M |
| Q3 2024 | 23 | $630.7K |
| Q2 2024 | 19 | $433.8K |
| Q1 2024 | 16 | $647.4K |
| Q4 2023 | 18 | $3.12M |
| Q3 2023 | 28 | $860.6K |
| Q2 2023 | 31 | $2.39M |
| Q1 2023 | 30 | $1.71M |
| Q4 2022 | 27 | $629.7K |
| Q3 2022 | 30 | $1.38M |
| Q2 2022 | 28 | $2.82M |
| Q1 2022 | 28 | $6.66M |
| Q4 2021 | 29 | $5.17M |
| Q3 2021 | 37 | $9.14M |
| Q2 2021 | 29 | $11.7M |
| Q1 2021 | 18 | $5.45M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Vivos Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 85,001 | $38.6K | 0.00% | −10,542−11.0% | Reduced |
| IHT Wealth Management, LLC | 76,736 | $34.9K | 0.00% | +35,675+86.9% | Added |
| Vanguard Capital Management LLC | 60,629 | $27.6K | 0.00% | −212,700−77.8% | Reduced |
| Commonwealth Equity Services, LLC | 42,500 | $19.3K | 0.00% | 00.0% | Unchanged |
| National Asset Management, Inc. | 38,066 | $18.8K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 39,154 | $17.8K | 0.00% | +28,108+254.5% | Added |
| Centurion Wealth Management LLC | 35,684 | $16.2K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 27,817 | $12.6K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 24,922 | $11.3K | 0.00% | 00.0% | Unchanged |
| Sequoia Financial Advisors, LLC | 24,000 | $10.9K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 23,432 | $10.7K | 0.00% | −7,400−24.0% | Reduced |
| Northern Trust Corp | 20,775 | $9.44K | 0.00% | +8,264+66.1% | Added |
| Acorn Wealth Advisors, LLC | 14,776 | $6.72K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 10,075 | $4.58K | 0.00% | +10,075 | New |
| Tower Research Capital LLC (TRC) | 5,211 | $2.37K | 0.00% | −2,177−29.5% | Reduced |
| Advisor Group Holdings, Inc. | 1,143 | $516 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 547 | $249 | 0.00% | 00.0% | Unchanged |
| Ronald Blue Trust, Inc. | 160 | $73 | 0.00% | 00.0% | Unchanged |
| Kozak & Associates, Inc. | 49 | $24 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 23 | $10 | 0.00% | +23 | New |
| Morgan Stanley | 7 | $3 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −1,115,859−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −25,117−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |